| pubmed-article:6855461 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6855461 | lifeskim:mentions | umls-concept:C1267092 | lld:lifeskim |
| pubmed-article:6855461 | lifeskim:mentions | umls-concept:C0205216 | lld:lifeskim |
| pubmed-article:6855461 | lifeskim:mentions | umls-concept:C1656251 | lld:lifeskim |
| pubmed-article:6855461 | pubmed:issue | 23 | lld:pubmed |
| pubmed-article:6855461 | pubmed:dateCreated | 1983-7-15 | lld:pubmed |
| pubmed-article:6855461 | pubmed:abstractText | The ATP-dependent azide-insensitive Ca-uptake by the postnuclear supernatant from rat myometrium is stimulated more by 5 mM oxalate than by 25 mM phosphate. During subcellular fractionation, however, the percent recovery of the oxalate stimulated Ca-uptake diminishes more rapidly than that of the Ca-uptake without any added oxalate or phosphate. The percent recovery of the phosphate stimulated Ca-uptake also diminishes but not to as low levels as that of the oxalate stimulated Ca-uptake. The net result is higher stimulation of this uptake by 25 mM phosphate than by 5 mM oxalate in the various sucrose density gradient fractions. This discrepancy in percent recoveries presents a major concern about the use of oxalate or phosphate stimulated Ca-uptake as a marker for smooth muscle membranes. | lld:pubmed |
| pubmed-article:6855461 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6855461 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6855461 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6855461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6855461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6855461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6855461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6855461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6855461 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6855461 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:6855461 | pubmed:issn | 0024-3205 | lld:pubmed |
| pubmed-article:6855461 | pubmed:author | pubmed-author:GroverA KAK | lld:pubmed |
| pubmed-article:6855461 | pubmed:author | pubmed-author:JannRR | lld:pubmed |
| pubmed-article:6855461 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6855461 | pubmed:day | 6 | lld:pubmed |
| pubmed-article:6855461 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:6855461 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6855461 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6855461 | pubmed:pagination | 2655-60 | lld:pubmed |
| pubmed-article:6855461 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:meshHeading | pubmed-meshheading:6855461-... | lld:pubmed |
| pubmed-article:6855461 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6855461 | pubmed:articleTitle | Oxalate-stimulation of ATP-dependent Ca-uptake is diminished during smooth muscle subcellular fractionation. | lld:pubmed |
| pubmed-article:6855461 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6855461 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6855461 | lld:pubmed |
